Industry Research Reports
Home > Reports > Service & Software > Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-03-09
Pages: 112 Pages
Report ld: 6095229
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urine Drug Testing Service Market Size(US$)
CAGR 2026-2032
4.6%
Market Size,2032
USD 2,946
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,247 million
Market Forecast in 2032(Value)
US$ 2,946 million
CAGR
4.6%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Urine Drug Testing Service was estimated to be worth US$ 2157 million in 2025 and is projected to reach US$ 2946 million, growing at a CAGR of 4.6% from 2026 to 2032.
Urine Drug Testing Service refers to the process of analyzing a urine sample to detect the presence or absence of specific drugs or their metabolites, typically used for clinical, occupational, legal, or forensic purposes. This service is widely recognized as one of the most common and non-invasive drug testing methods due to its ease of sample collection, cost-effectiveness, and relatively long detection window for many substances. Urine drug testing can detect a wide range of substances, including cannabinoids, amphetamines, opioids, cocaine, benzodiazepines, and other prescription or illicit drugs. It is commonly employed in workplace drug screening programs, pre-employment checks, post-incident investigations, law enforcement, rehabilitation monitoring, and clinical diagnosis.
The North American market for Urine Drug Testing Service was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Urine Drug Testing Service was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Urine Drug Testing Service was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Urine Drug Testing Service market include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health, Keystone Laboratories, Crystal Health, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Urine Drug Testing Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Urine Drug Testing Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Urine Drug Testing Service.
MARKET SEGMENTATION
By Company
- Abbott
- Labcorp
- Quest Diagnostics
- Millennium Health
- Genesis Reference Labs
- Concentra
- DISA
- Medigold Health
- Keystone Laboratories
- Crystal Health
- MedTox
- Australian Clinical Labs
- Dominion Diagnostics
- Matrix Diagnostics
- Dorevitch Pathology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- On-site Testing
- Laboratory-based Testing
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Urine Drug Testing Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Urine Drug Testing Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Urine Drug Testing Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Urine Drug Testing Service Product Introduction
1.2 Global Urine Drug Testing Service Market Size Forecast (2021–2032)
1.3 Urine Drug Testing Service Market Trends & Drivers
1.3.1 Urine Drug Testing Service Industry Trends
1.3.2 Urine Drug Testing Service Market Drivers & Opportunities
1.3.3 Urine Drug Testing Service Market Challenges
1.3.4 Urine Drug Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Urine Drug Testing Service Players Revenue Ranking (2025)
2.2 Global Urine Drug Testing Service Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Urine Drug Testing Service Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Urine Drug Testing Service
2.6 Urine Drug Testing Service Market Competitive Analysis
2.6.1 Urine Drug Testing Service Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Urine Drug Testing Service Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urine Drug Testing Service revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Urine Drug Testing Service Market Classification
3.1 Introduction by Type
3.1.1 On-site Testing
3.1.2 Laboratory-based Testing
3.1.3 Global Urine Drug Testing Service Sales Value by Type
3.1.3.1 Global Urine Drug Testing Service Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Urine Drug Testing Service Sales Value, by Type (2021–2032)
3.1.3.3 Global Urine Drug Testing Service Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Urine Drug Testing Service Sales Value by Application
4.2.1 Global Urine Drug Testing Service Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Urine Drug Testing Service Sales Value by Application (2021–2032)
4.2.3 Global Urine Drug Testing Service Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Urine Drug Testing Service Sales Value by Region
5.1.1 Global Urine Drug Testing Service Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Urine Drug Testing Service Sales Value by Region (2021–2026)
5.1.3 Global Urine Drug Testing Service Sales Value by Region (2027–2032)
5.1.4 Global Urine Drug Testing Service Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Urine Drug Testing Service Sales Value, 2021–2032
5.2.2 North America Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Urine Drug Testing Service Sales Value, 2021–2032
5.3.2 Europe Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Urine Drug Testing Service Sales Value, 2021–2032
5.4.2 Asia Pacific Urine Drug Testing Service Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Urine Drug Testing Service Sales Value, 2021–2032
5.5.2 South America Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Urine Drug Testing Service Sales Value, 2021–2032
5.6.2 Middle East & Africa Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Urine Drug Testing Service Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Urine Drug Testing Service Sales Value, 2021–2032
6.3 United States
6.3.1 United States Urine Drug Testing Service Sales Value, 2021–2032
6.3.2 United States Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Urine Drug Testing Service Sales Value, 2021–2032
6.4.2 Europe Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Urine Drug Testing Service Sales Value, 2021–2032
6.5.2 China Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.5.3 China Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Urine Drug Testing Service Sales Value, 2021–2032
6.6.2 Japan Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Urine Drug Testing Service Sales Value, 2021–2032
6.7.2 South Korea Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Urine Drug Testing Service Sales Value, 2021–2032
6.8.2 Southeast Asia Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Urine Drug Testing Service Sales Value, 2021–2032
6.9.2 India Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
6.9.3 India Urine Drug Testing Service Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Profile
7.1.2 Abbott Main Business
7.1.3 Abbott Urine Drug Testing Service Products, Services, and Solutions
7.1.4 Abbott Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.1.5 Abbott Recent Developments
7.2 Labcorp
7.2.1 Labcorp Profile
7.2.2 Labcorp Main Business
7.2.3 Labcorp Urine Drug Testing Service Products, Services, and Solutions
7.2.4 Labcorp Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.2.5 Labcorp Recent Developments
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Profile
7.3.2 Quest Diagnostics Main Business
7.3.3 Quest Diagnostics Urine Drug Testing Service Products, Services, and Solutions
7.3.4 Quest Diagnostics Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.3.5 Quest Diagnostics Recent Developments
7.4 Millennium Health
7.4.1 Millennium Health Profile
7.4.2 Millennium Health Main Business
7.4.3 Millennium Health Urine Drug Testing Service Products, Services, and Solutions
7.4.4 Millennium Health Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.4.5 Millennium Health Recent Developments
7.5 Genesis Reference Labs
7.5.1 Genesis Reference Labs Profile
7.5.2 Genesis Reference Labs Main Business
7.5.3 Genesis Reference Labs Urine Drug Testing Service Products, Services, and Solutions
7.5.4 Genesis Reference Labs Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.5.5 Genesis Reference Labs Recent Developments
7.6 Concentra
7.6.1 Concentra Profile
7.6.2 Concentra Main Business
7.6.3 Concentra Urine Drug Testing Service Products, Services, and Solutions
7.6.4 Concentra Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.6.5 Concentra Recent Developments
7.7 DISA
7.7.1 DISA Profile
7.7.2 DISA Main Business
7.7.3 DISA Urine Drug Testing Service Products, Services, and Solutions
7.7.4 DISA Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.7.5 DISA Recent Developments
7.8 Medigold Health
7.8.1 Medigold Health Profile
7.8.2 Medigold Health Main Business
7.8.3 Medigold Health Urine Drug Testing Service Products, Services, and Solutions
7.8.4 Medigold Health Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.8.5 Medigold Health Recent Developments
7.9 Keystone Laboratories
7.9.1 Keystone Laboratories Profile
7.9.2 Keystone Laboratories Main Business
7.9.3 Keystone Laboratories Urine Drug Testing Service Products, Services, and Solutions
7.9.4 Keystone Laboratories Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.9.5 Keystone Laboratories Recent Developments
7.10 Crystal Health
7.10.1 Crystal Health Profile
7.10.2 Crystal Health Main Business
7.10.3 Crystal Health Urine Drug Testing Service Products, Services, and Solutions
7.10.4 Crystal Health Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.10.5 Crystal Health Recent Developments
7.11 MedTox
7.11.1 MedTox Profile
7.11.2 MedTox Main Business
7.11.3 MedTox Urine Drug Testing Service Products, Services, and Solutions
7.11.4 MedTox Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.11.5 MedTox Recent Developments
7.12 Australian Clinical Labs
7.12.1 Australian Clinical Labs Profile
7.12.2 Australian Clinical Labs Main Business
7.12.3 Australian Clinical Labs Urine Drug Testing Service Products, Services, and Solutions
7.12.4 Australian Clinical Labs Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.12.5 Australian Clinical Labs Recent Developments
7.13 Dominion Diagnostics
7.13.1 Dominion Diagnostics Profile
7.13.2 Dominion Diagnostics Main Business
7.13.3 Dominion Diagnostics Urine Drug Testing Service Products, Services, and Solutions
7.13.4 Dominion Diagnostics Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.13.5 Dominion Diagnostics Recent Developments
7.14 Matrix Diagnostics
7.14.1 Matrix Diagnostics Profile
7.14.2 Matrix Diagnostics Main Business
7.14.3 Matrix Diagnostics Urine Drug Testing Service Products, Services, and Solutions
7.14.4 Matrix Diagnostics Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.14.5 Matrix Diagnostics Recent Developments
7.15 Dorevitch Pathology
7.15.1 Dorevitch Pathology Profile
7.15.2 Dorevitch Pathology Main Business
7.15.3 Dorevitch Pathology Urine Drug Testing Service Products, Services, and Solutions
7.15.4 Dorevitch Pathology Urine Drug Testing Service Revenue (US$ Million), 2021–2026
7.15.5 Dorevitch Pathology Recent Developments
8 Industry Chain Analysis
8.1 Urine Drug Testing Service Value Chain
8.2 Urine Drug Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Urine Drug Testing Service Sales Model
8.5.2 Sales Channels
8.5.3 Urine Drug Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Urine Drug Testing Service Market Trends
Table 2. Urine Drug Testing Service Market Drivers & Opportunities
Table 3. Urine Drug Testing Service Market Challenges
Table 4. Urine Drug Testing Service Market Restraints
Table 5. Global Urine Drug Testing Service Revenue by Company (US$ Million), 2021–2026
Table 6. Global Urine Drug Testing Service Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Urine Drug Testing Service Product Type
Table 9. Key Companies General Availability (GA) Timeline for Urine Drug Testing Service
Table 10. Global Urine Drug Testing Service Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urine Drug Testing Service revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Urine Drug Testing Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Urine Drug Testing Service Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Urine Drug Testing Service Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Urine Drug Testing Service Sales Market Share in Value by Type (2021–2026)
Table 17. Global Urine Drug Testing Service Sales Market Share in Value by Type (2027–2032)
Table 18. Global Urine Drug Testing Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Urine Drug Testing Service Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Urine Drug Testing Service Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Urine Drug Testing Service Sales Market Share in Value by Application (2021–2026)
Table 22. Global Urine Drug Testing Service Sales Market Share in Value by Application (2027–2032)
Table 23. Global Urine Drug Testing Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Urine Drug Testing Service Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Urine Drug Testing Service Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Urine Drug Testing Service Sales Value by Region (%), 2021–2026
Table 27. Global Urine Drug Testing Service Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Urine Drug Testing Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Urine Drug Testing Service Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Urine Drug Testing Service Sales Value, (US$ Million), 2027–2032
Table 31. Abbott Basic Information List
Table 32. Abbott Description and Business Overview
Table 33. Abbott Urine Drug Testing Service Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Urine Drug Testing Service Business of Abbott (2021–2026)
Table 35. Abbott Recent Developments
Table 36. Labcorp Basic Information List
Table 37. Labcorp Description and Business Overview
Table 38. Labcorp Urine Drug Testing Service Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Urine Drug Testing Service Business of Labcorp (2021–2026)
Table 40. Labcorp Recent Developments
Table 41. Quest Diagnostics Basic Information List
Table 42. Quest Diagnostics Description and Business Overview
Table 43. Quest Diagnostics Urine Drug Testing Service Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Urine Drug Testing Service Business of Quest Diagnostics (2021–2026)
Table 45. Quest Diagnostics Recent Developments
Table 46. Millennium Health Basic Information List
Table 47. Millennium Health Description and Business Overview
Table 48. Millennium Health Urine Drug Testing Service Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Urine Drug Testing Service Business of Millennium Health (2021–2026)
Table 50. Millennium Health Recent Developments
Table 51. Genesis Reference Labs Basic Information List
Table 52. Genesis Reference Labs Description and Business Overview
Table 53. Genesis Reference Labs Urine Drug Testing Service Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Urine Drug Testing Service Business of Genesis Reference Labs (2021–2026)
Table 55. Genesis Reference Labs Recent Developments
Table 56. Concentra Basic Information List
Table 57. Concentra Description and Business Overview
Table 58. Concentra Urine Drug Testing Service Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Urine Drug Testing Service Business of Concentra (2021–2026)
Table 60. Concentra Recent Developments
Table 61. DISA Basic Information List
Table 62. DISA Description and Business Overview
Table 63. DISA Urine Drug Testing Service Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Urine Drug Testing Service Business of DISA (2021–2026)
Table 65. DISA Recent Developments
Table 66. Medigold Health Basic Information List
Table 67. Medigold Health Description and Business Overview
Table 68. Medigold Health Urine Drug Testing Service Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Urine Drug Testing Service Business of Medigold Health (2021–2026)
Table 70. Medigold Health Recent Developments
Table 71. Keystone Laboratories Basic Information List
Table 72. Keystone Laboratories Description and Business Overview
Table 73. Keystone Laboratories Urine Drug Testing Service Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Urine Drug Testing Service Business of Keystone Laboratories (2021–2026)
Table 75. Keystone Laboratories Recent Developments
Table 76. Crystal Health Basic Information List
Table 77. Crystal Health Description and Business Overview
Table 78. Crystal Health Urine Drug Testing Service Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Urine Drug Testing Service Business of Crystal Health (2021–2026)
Table 80. Crystal Health Recent Developments
Table 81. MedTox Basic Information List
Table 82. MedTox Description and Business Overview
Table 83. MedTox Urine Drug Testing Service Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Urine Drug Testing Service Business of MedTox (2021–2026)
Table 85. MedTox Recent Developments
Table 86. Australian Clinical Labs Basic Information List
Table 87. Australian Clinical Labs Description and Business Overview
Table 88. Australian Clinical Labs Urine Drug Testing Service Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Urine Drug Testing Service Business of Australian Clinical Labs (2021–2026)
Table 90. Australian Clinical Labs Recent Developments
Table 91. Dominion Diagnostics Basic Information List
Table 92. Dominion Diagnostics Description and Business Overview
Table 93. Dominion Diagnostics Urine Drug Testing Service Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Urine Drug Testing Service Business of Dominion Diagnostics (2021–2026)
Table 95. Dominion Diagnostics Recent Developments
Table 96. Matrix Diagnostics Basic Information List
Table 97. Matrix Diagnostics Description and Business Overview
Table 98. Matrix Diagnostics Urine Drug Testing Service Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Urine Drug Testing Service Business of Matrix Diagnostics (2021–2026)
Table 100. Matrix Diagnostics Recent Developments
Table 101. Dorevitch Pathology Basic Information List
Table 102. Dorevitch Pathology Description and Business Overview
Table 103. Dorevitch Pathology Urine Drug Testing Service Products, Services, and Solutions
Table 104. Revenue (US$ Million) in Urine Drug Testing Service Business of Dorevitch Pathology (2021–2026)
Table 105. Dorevitch Pathology Recent Developments
Table 106. Revenue (US$ Million) in Urine Drug Testing Service Business of Company 40 (2021–2026)
Table 107. Company 40 Recent Developments
Table 108. Key Raw Materials Lists
Table 109. Key Suppliers of Raw Materials Lists
Table 110. Urine Drug Testing Service Downstream Customers
Table 111. Urine Drug Testing Service Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Urine Drug Testing Service Product Picture
Figure 2. Global Urine Drug Testing Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 4. Urine Drug Testing Service Report Years Considered
Figure 5. Global Urine Drug Testing Service Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Urine Drug Testing Service Revenue in 2025
Figure 7. Urine Drug Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. On-site Testing Picture
Figure 9. Laboratory-based Testing Picture
Figure 10. Global Urine Drug Testing Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Urine Drug Testing Service Sales Value Market Share by Type, 2025 & 2032
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Others
Figure 15. Global Urine Drug Testing Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Urine Drug Testing Service Sales Value Market Share by Application, 2025 & 2032
Figure 17. North America Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 18. North America Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
Figure 19. Europe Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 20. Europe Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
Figure 21. Asia Pacific Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 22. Asia Pacific Urine Drug Testing Service Sales Value by Subregion (%), 2025 vs 2032
Figure 23. South America Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 24. South America Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
Figure 25. Middle East & Africa Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 26. Middle East & Africa Urine Drug Testing Service Sales Value by Country (%), 2025 vs 2032
Figure 27. Key Countries/Regions Urine Drug Testing Service Sales Value (%), 2021–2032
Figure 28. United States Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 29. United States Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 30. United States Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 31. Europe Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 32. Europe Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 33. Europe Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 34. China Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 35. China Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 36. China Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 37. Japan Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 38. Japan Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 39. Japan Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 40. South Korea Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 41. South Korea Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 42. South Korea Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 43. Southeast Asia Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 44. Southeast Asia Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 45. Southeast Asia Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 46. India Urine Drug Testing Service Sales Value (US$ Million), 2021–2032
Figure 47. India Urine Drug Testing Service Sales Value by Type (%), 2025 vs 2032
Figure 48. India Urine Drug Testing Service Sales Value by Application (%), 2025 vs 2032
Figure 49. Urine Drug Testing Service Value Chain
Figure 50. Urine Drug Testing Service Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Urine Drug Testing Service market?
The top companies in the global Urine Drug Testing Service market are Abbott、Labcorp、Quest Diagnostics.
What is the annual compound growth rate of the global Urine Drug Testing Service market size from 2026 to 2032?
Which region is expected to have the highest market share?
What was the global market size of Urine Drug Testing Service in 2032?
What was the global market size of Urine Drug Testing Service in 2026?
Related Reports
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 132
USD 4900.00
(Single User License)
Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urine Drug Testing Service market size was US$ 2157 million in 2025 and is forecast to reach a readjusted size of US$ 2946 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 98
USD 4250.00
(Single User License)
Global Urine Drug Testing Service Market Research Report 2026
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 118
USD 2900.00
(Single User License)
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urine Drug Testing Service market is projected to grow from US$ 2085 million in 2024 to US$ 2829 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-13
Pages: 136
USD 4900.00
(Single User License)
Global Urine Drug Testing Service Market Research Report 2025
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-08-13
Pages: 87
USD 2900.00
(Single User License)
Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 116
USD 3950.00
(Single User License)
Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 98
USD 4250.00
(Single User License)
Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 132
USD 4900.00 (Single User License)Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urine Drug Testing Service market size was US$ 2157 million in 2025 and is forecast to reach a readjusted size of US$ 2946 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 98
USD 4250.00 (Single User License)Global Urine Drug Testing Service Market Research Report 2026
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 118
USD 2900.00 (Single User License)Global Urine Drug Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urine Drug Testing Service market is projected to grow from US$ 2085 million in 2024 to US$ 2829 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-13
Pages: 136
USD 4900.00 (Single User License)Global Urine Drug Testing Service Market Research Report 2025
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-08-13
Pages: 87
USD 2900.00 (Single User License)Urine Drug Testing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 116
USD 3950.00 (Single User License)Global Urine Drug Testing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 98
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now